Ronald Brus Email and Phone Number
Ronald Brus work email
- Valid
- Valid
Ronald Brus personal email
- Valid
Ronald Brus phone numbers
Ronald Brus is a physician with a passion for the biopharmaceutical industry. He serves as CEO of myTomorrows, a company he founded that bridges the gap between patients who are searching for treatment options and the pharmaceutical companies who provide them. He is also the co-founder and CBO of Leyden Labs, a company targeting commonalities of respiratory viruses to protect against known and future viral outbreaks. He spent 14 years at Crucell, a biotechnology company specializing in vaccines, serving in various roles including CEO, COO, CBO and EVP of business development. Dr. Brus also formerly served as a member of the executive committee for Galapagos.Dr. Brus earned his medical degree from the University of Groningen.
-
Founder And CeoMytomorrows.Com 2012 - PresentAmsterdam, Noord Holland, NlmyTomorrows was founded by physicians and experts from the pharmaceutical industry who want to facilitate early access to the latest drug innovations for patients with high unmet needs, who are excluded from clinical trials.Seriously ill patients are increasingly aware of the latest drug developments in their disease area. Sometimes patients can participate in clinical trials, but more often they cannot. For these patients and their physicians, myTomorrows is building a bridge to drug developers.myTomorrows was launched in April 2013, and operates in a growing number of European countries and will expand to the US in 2017.
-
Co-Founder And CboLeyden Labs 2020 - PresentAmsterdam, North Holland, NlCo-founded a company dedicated to freeing humanity from the burden of respiratory illnessesLeyden Labs aims to help people live their lives to the fullest by advancing a portfolio of accessible intranasal product candidates. We seek to provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. -
Co-Founder Tested.MeTested.Me 2020 - PresentLondon, Select State, Gbtested.me is your digital partner in the pandemic. Powered by patented AI and biometric identification tools, our technology is your passport to getting back to your personal and professional lives, safely and responsibly. Because ‘good for the economy’ should also mean ‘good for the community’. -
Board Of Directors FeyenoordFeyenoord Rotterdam N.V. 2020 - PresentRotterdam, Nl -
Member Of The Executive CommitteeGalapagos 2010 - 2011Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines.
-
CeoCrucell 2004 - 2011Crucell is a biotechnology company specializing in vaccines and biopharmaceutical technologies. Crucell develops and licenses technologies related to the discovery and manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and gene therapy products.The firm, a subsidiary of Johnson & Johnson, is headquartered in Leiden, Netherlands. Crucell shares were previously listed on the Euronext Amsterdam exchange and formed part of the AMX index until April 2011, when J&J completed a tender offer for the company. -
CooCrucell 2003 - 2004Crucell is a biotechnology company specializing in vaccines and biopharmaceutical technologies. Crucell develops and licenses technologies related to the discovery and manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and gene therapy products.The firm, a subsidiary of Johnson & Johnson, is headquartered in Leiden, Netherlands. Crucell shares were previously listed on the Euronext Amsterdam exchange and formed part of the AMX index until April 2011, when J&J completed a tender offer for the company.
-
CboCrucell 2000 - 2003Crucell is a biotechnology company specializing in vaccines and biopharmaceutical technologies. Crucell develops and licenses technologies related to the discovery and manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and gene therapy products.The firm, a subsidiary of Johnson & Johnson, is headquartered in Leiden, Netherlands. Crucell shares were previously listed on the Euronext Amsterdam exchange and formed part of the AMX index until April 2011, when J&J completed a tender offer for the company.
-
Executive Vice President Business DevelopmentCrucell 1997 - 2000Crucell is a biotechnology company specializing in vaccines and biopharmaceutical technologies. Crucell develops and licenses technologies related to the discovery and manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and gene therapy products.The firm, a subsidiary of Johnson & Johnson, is headquartered in Leiden, Netherlands. Crucell shares were previously listed on the Euronext Amsterdam exchange and formed part of the AMX index until April 2011, when J&J completed a tender offer for the company.
-
Member Of The Executive CommitteeGalapagos 2000 - 2003Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines.
-
Product Planning PhysicianForest Laboratories 1994 - 1996On July 1, 2014, Actavis completed the acquisition of Forest Laboratories, creating one of the world’s fastest-growing specialty pharmaceutical companies with annual revenues of more than $15 billion anticipated for 2015.The combination of Actavis and Forest creates a new breed of specialty pharmaceutical company, with size and scale, a balanced offering of strong brands and generics, a focus on strategic, lower-risk drug development and a flexible, scalable business model that permits it to adapt quickly to ever-changing industry dynamics and drive sustainable, long-term organic growth.
-
Medical DirectorZambon B.V. 1990 - 1994Zambon is a leading pharmaceutical and chemical multinational with a reputation for inventive and innovative thinking, flexibility and customer focus.
Ronald Brus Skills
Ronald Brus Education Details
-
University Of GroningenDoctor Of Medicine (Md)
Frequently Asked Questions about Ronald Brus
What company does Ronald Brus work for?
Ronald Brus works for Mytomorrows.com
What is Ronald Brus's role at the current company?
Ronald Brus's current role is Founder and CEO myTomorrows/Co-founder and Chief Growth Officer Leyden Labs.
What is Ronald Brus's email address?
Ronald Brus's email address is br****@****ail.com
What is Ronald Brus's direct phone number?
Ronald Brus's direct phone number is +318852*****
What schools did Ronald Brus attend?
Ronald Brus attended University Of Groningen.
What skills is Ronald Brus known for?
Ronald Brus has skills like Business Development, Start Ups, Pharmaceutical Industry, Biotechnology, Strategy, Entrepreneurship, Life Sciences, Technology Transfer, Management, Venture Capital, Business Strategy, Product Development.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial